The Crofoot Research Center
ABOUT US
The Crofoot Research Center, INC. is proud to be a leading center for the research of HIV, Hepatitis C, and Covid-19 treatments and preventatives in Houston and South Texas.
Our Research Department conducts Phase I-IV studies and is comprised of Physicians, Nurse Practitioners, a Physician Assistant, a Vocational Nurse, dedicated Research Assistants, and Certified Clinical Research Professionals. Participation in clinical research allows us to offer our patients experimental treatment options that are not available elsewhere in the city, the state, and sometimes the Southeast United States.
The Crofoot Research Center, INC. is among some of the most respected clinical trial sites in Houston, TX, and excels at providing our patients as well as those from referring physicians with state-of-the-art treatment options and a highly patient-focused medical experience that respects privacy and dignity.
For information on our current Clinical Trials, including HIV research studies, please contact us or complete our fillable form.
The Crofoot Research Center, INC.
3701 Kirby Drive Suite 1230
Houston, TX 77098
P: (713) 526-0005
F: (888) 895-1243
PUBLICATIONS & PRESENTATIONS
Dr. Gordon Crofoot and the Crofoot Research Center, INC have had the pleasure of completing various research studies. Learn more about the studies we have completed. Read their publications and presentations by clicking the button below.
-
A Phase 3, Randomized, Active-controlled, Double-blind Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir (B/F/TAF) CLICK HERE TO LEARN MORE
-
A Phase 3 Randomized, Active-Controlled, Open-Label Study to Evaluate a Switch to an Oral Weekly Islatravir/ Lenacapavir Regimen in People with HIV-1 Who are Virologically Suppressed on Standard of Care CLICK HERE TO LEARN MORE
-
A Phase 2 Randomized, Placebo-controlled Study of the Safety and Efficacy of Obeldesivir to Treat Non-hospitalized Adults with Acute Respiratory Syncytial Virus (RSV) Infection CLICK HERE TO LEARN MORE
-
An Interventional Efficacy and Safety, Phase 3, Double-Blind, 2-Arm Study to Investigate Orally Administered Ibuzatrelvir Compared With Placebo in Non-Hospitalized Symptomatic Adult and Adolescent Participants With COVID-19 Who Are at High Risk of Progressing to Severe Illness. CLICK HERE TO LEARN MORE
STUDIES WE ARE CURRENTLY ENROLLING FOR:
Are you interested in participating in a clinical research trial?
Fill out our form below and we will contact you regarding trials you may qualify for.
Meet the Research Team
-
Keith (Kota)
Clinical Research Manager
-
Daniel
Certified Clinical Research Coordinator
-
Juston
Clinical Research Coordinator
-
Bert
Clinical Research Nurse
-
Ashley
Clinical Research Assistant
-
David
Clinical Research Assistant
-
Kasie
Clinical Research Assistant